{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "29",
                "@timestamp": "2023-04-29T10:56:09.000009-04:00",
                "@year": "2023",
                "@month": "04"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "National Institutes of Health",
                    "xocs:funding-agency-acronym": "NIH",
                    "xocs:funding-agency": "National Institutes of Health",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000002",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "National Heart, Lung, and Blood Institute",
                    "xocs:funding-agency-acronym": "NHLBI",
                    "xocs:funding-agency": "National Heart, Lung, and Blood Institute",
                    "xocs:funding-id": "U01HL143365",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000050",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-03-01T18:11:40.378Z",
            "xocs:funding-text": "Acknowledgment This work was supported by the National Heart, Lung, and Blood Institute, National Institutes of Health (U01HL143365).",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60002746",
                            "@country": "usa",
                            "city": "Cambridge",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Mount Auburn Hospital"},
                                {"$": "Harvard Medical School"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002746",
                                    "@dptid": "113387201"
                                },
                                {"@afid": "60026642"}
                            ],
                            "state": "MA",
                            "@affiliation-instance-id": "2011906524-e8618d3416eca98332631d4c15d47d32",
                            "ce:source-text": "Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA",
                            "@dptid": "113387201"
                        },
                        "author": [{
                            "ce:given-name": "Soravis",
                            "preferred-name": {
                                "ce:given-name": "Soravis",
                                "ce:initials": "S.",
                                "ce:surname": "Osataphan",
                                "ce:indexed-name": "Osataphan S."
                            },
                            "@author-instance-id": "2011906524-2edc6e36f5c3c4453658f353f0ea9fb1",
                            "@seq": "1",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Osataphan",
                            "@auid": "57189993888",
                            "ce:indexed-name": "Osataphan S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60002746",
                            "@country": "usa",
                            "city": "Boston",
                            "organization": [
                                {"$": "Division of Hemostasis and Thrombosis"},
                                {"$": "Beth Israel Deaconess Medical Center"},
                                {"$": "Harvard Medical School"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002746",
                                    "@dptid": "103189050"
                                },
                                {"@afid": "60030058"}
                            ],
                            "state": "MA",
                            "@affiliation-instance-id": "2011906524-4e7177fbc824aa4f43eabda488df26cc",
                            "ce:source-text": "Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA",
                            "@dptid": "103189050"
                        },
                        "author": [
                            {
                                "ce:given-name": "Rushad",
                                "preferred-name": {
                                    "ce:given-name": "Rushad",
                                    "ce:initials": "R.",
                                    "ce:surname": "Patell",
                                    "ce:indexed-name": "Patell R."
                                },
                                "@author-instance-id": "2011906524-bc7dd1f2998b440c10042c6efb7a0918",
                                "@seq": "2",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Patell",
                                "@auid": "54682133800",
                                "@orcid": "0000-0002-8426-3398",
                                "ce:indexed-name": "Patell R."
                            },
                            {
                                "ce:given-name": "Thita",
                                "preferred-name": {
                                    "ce:given-name": "Thita",
                                    "ce:initials": "T.",
                                    "ce:surname": "Chiasakul",
                                    "ce:indexed-name": "Chiasakul T."
                                },
                                "@author-instance-id": "2011906524-20b14ac62e9864bfa40e3f845ddbeb02",
                                "@seq": "3",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chiasakul",
                                "@auid": "56938997200",
                                "@orcid": "0000-0002-0443-1751",
                                "ce:indexed-name": "Chiasakul T."
                            },
                            {
                                "ce:given-name": "Jeffrey I.",
                                "preferred-name": {
                                    "ce:given-name": "Jeffrey I.",
                                    "ce:initials": "J.I.",
                                    "ce:surname": "Zwicker",
                                    "ce:indexed-name": "Zwicker J.I."
                                },
                                "@author-instance-id": "2011906524-0b9505ac9479c902339dac1c4f99b098",
                                "@seq": "5",
                                "ce:initials": "J.I.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Zwicker",
                                "@auid": "7003326377",
                                "@orcid": "0000-0001-5810-6893",
                                "ce:indexed-name": "Zwicker J.I."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Hematology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60028190",
                                    "@dptid": "113019942"
                                },
                                {"@afid": "60031780"},
                                {"@afid": "60022183"}
                            ],
                            "@affiliation-instance-id": "2011906524-cbe34e2657b9310db10032011d8df6fe",
                            "ce:source-text": "Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Thita",
                            "preferred-name": {
                                "ce:given-name": "Thita",
                                "ce:initials": "T.",
                                "ce:surname": "Chiasakul",
                                "ce:indexed-name": "Chiasakul T."
                            },
                            "@author-instance-id": "2011906524-20b14ac62e9864bfa40e3f845ddbeb02",
                            "@seq": "3",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chiasakul",
                            "@auid": "56938997200",
                            "@orcid": "0000-0002-0443-1751",
                            "ce:indexed-name": "Chiasakul T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60032732",
                            "@country": "usa",
                            "city": "Cleveland",
                            "organization": [
                                {"$": "Department of Hematology and Medical Oncology"},
                                {"$": "Taussig Cancer Institute"},
                                {"$": "Case Comprehensive Cancer Center"},
                                {"$": "Cleveland Clinic"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60032732",
                                    "@dptid": "104666632"
                                },
                                {"@afid": "60000305"},
                                {"@afid": "60021578"},
                                {"@afid": "60021160"}
                            ],
                            "state": "OH",
                            "@affiliation-instance-id": "2011906524-068a2c0be0f6479781c5cc1a6e3a00f9",
                            "ce:source-text": "Department of Hematology and Medical Oncology, Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland Clinic, Cleveland, OH",
                            "@dptid": "104666632"
                        },
                        "author": [{
                            "ce:given-name": "Alok A.",
                            "preferred-name": {
                                "ce:given-name": "Alok A.",
                                "ce:initials": "A.A.",
                                "ce:surname": "Khorana",
                                "ce:indexed-name": "Khorana A.A."
                            },
                            "@author-instance-id": "2011906524-6c47ae1e2aa0992960382e6bf8e5f6a4",
                            "@seq": "4",
                            "ce:initials": "A.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Khorana",
                            "@auid": "7003928027",
                            "ce:indexed-name": "Khorana A.A."
                        }]
                    }
                ],
                "citation-title": "Extended thromboprophylaxis for medically ill patients with cancer: A systemic review and meta-analysis",
                "abstracts": "© 2021 by The American Society of Hematology.Hospitalized medically ill patients with cancer are at increased risk of both venous thromboembolism and bleeding. The safety and efficacy of extended thromboprophylaxis in patients with cancer are unclear.Weconducted a systematic review and meta-analysis of the literature using ofMEDLINE, EMBASE, and the Cochrane CENTRAL databases to identify cancer subgroups enrolled in randomized controlled trials evaluating extended thromboprophylaxis following hospitalization. The primary outcomes were symptomatic and incidental venous thromboembolic events and hemorrhage (major hemorrhage and clinically relevant nonmajor bleeding). Four randomized controlled trials reported the outcomes of extended thromboprophylaxis in 3655medically ill patients with active or history of cancer. The rates of venous thromboembolic events were similar between the extended-duration and standardduration groups (odds ratio [OR], 0.85; 95% confidence interval [CI], 0.61-1.18; I2=0%). However, major and clinically relevant nonmajor bleeding occurred significantly more frequently in the extended-duration thromboprophylaxis group (OR, 2.10; 95% CI, 1.33-3.35; I2 = 8%). Extended thromboprophylaxis in hospitalized medically ill patientswith cancerwas not associatedwith a reduced rate of venous thromboembolic events but was associated with increased risk of hemorrhage.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "address-part": "330 Brookline Ave",
                        "postal-code": "02215",
                        "@country": "usa",
                        "city": "Boston",
                        "organization": {"$": "Beth Israel Deaconess Medical Center"},
                        "state": "MA",
                        "ce:source-text": "Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215"
                    },
                    "person": {
                        "ce:given-name": "Jeffrey I.",
                        "ce:initials": "J.I.",
                        "ce:surname": "Zwicker",
                        "ce:indexed-name": "Zwicker J.I."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "re"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Blood Adv.",
                    "website": {"ce:e-address": {
                        "$": "https://ashpublications.org/bloodadvances/article/5/7/2003/475686/Prospective-KIR-genotype-evaluation-of",
                        "@type": "email"
                    }},
                    "@country": "usa",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": [
                        {
                            "$": "24739537",
                            "@type": "electronic"
                        },
                        {
                            "$": "24739529",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "5",
                            "@issue": "8"
                        },
                        "pagerange": {
                            "@first": "2055",
                            "@last": "2062"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "American Society of Hematology"},
                    "sourcetitle": "Blood Advances",
                    "@srcid": "21100886825",
                    "publicationdate": {
                        "year": "2021",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2021"
                        }
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "EMCLASS",
                        "classification": [
                            {
                                "classification-code": "16",
                                "classification-description": "Cancer"
                            },
                            {
                                "classification-code": "25",
                                "classification-description": "Hematology"
                            }
                        ]
                    },
                    {
                        "@type": "ASJC",
                        "classification": "2720"
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": "MEDI"
                    }
                ]}}
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Data-Review",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "28",
                    "@timestamp": "BST 09:23:24",
                    "@year": "2021",
                    "@month": "05"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2011906524",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "634818531",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "932867130",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210438694",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "33861298",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20211858296",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20211486343",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20219000224195",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85105062344",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85105062344",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1182/BLOODADVANCES.2020004118"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "34",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Heit JA, Crusan DJ, Ashrani AA, Petterson TM, Bailey KR. Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US. Blood. 2017; 130(2):109-114.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85023763009",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "130",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "109",
                                    "@last": "114"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JA",
                                    "@_fa": "true",
                                    "ce:surname": "Heit",
                                    "ce:indexed-name": "Heit JA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "DJ",
                                    "@_fa": "true",
                                    "ce:surname": "Crusan",
                                    "ce:indexed-name": "Crusan DJ"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AA",
                                    "@_fa": "true",
                                    "ce:surname": "Ashrani",
                                    "ce:indexed-name": "Ashrani AA"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "TM",
                                    "@_fa": "true",
                                    "ce:surname": "Petterson",
                                    "ce:indexed-name": "Petterson TM"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "KR.",
                                    "@_fa": "true",
                                    "ce:surname": "Bailey",
                                    "ce:indexed-name": "Bailey KR."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Heit JA, Crusan DJ, Ashrani AA, Petterson TM, Bailey KR. Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US. Blood. 2017; 130(2):109-114."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Flanders SA, Greene MT, Grant P, et al. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: A cohort study. JAMA Intern Med. 2014; 174(10):1577-1584.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: A cohort study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84907997115",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "174",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1577",
                                    "@last": "1584"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Flanders",
                                        "ce:indexed-name": "Flanders SA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MT",
                                        "@_fa": "true",
                                        "ce:surname": "Greene",
                                        "ce:indexed-name": "Greene MT"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Grant",
                                        "ce:indexed-name": "Grant P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Intern Med"
                        },
                        "ce:source-text": "Flanders SA, Greene MT, Grant P, et al. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: A cohort study. JAMA Intern Med. 2014; 174(10):1577-1584."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Chiasakul T, Evans CR, Spyropoulos AC, Raskob G, Crowther M, Cuker A. Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis. Thromb Res. 2019; 184:58-61.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85074504958",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "184"},
                                "pagerange": {
                                    "@first": "58",
                                    "@last": "61"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Chiasakul",
                                    "ce:indexed-name": "Chiasakul T"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "CR",
                                    "@_fa": "true",
                                    "ce:surname": "Evans",
                                    "ce:indexed-name": "Evans CR"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AC",
                                    "@_fa": "true",
                                    "ce:surname": "Spyropoulos",
                                    "ce:indexed-name": "Spyropoulos AC"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Raskob",
                                    "ce:indexed-name": "Raskob G"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Crowther",
                                    "ce:indexed-name": "Crowther M"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Cuker",
                                    "ce:indexed-name": "Cuker A."
                                }
                            ]},
                            "ref-sourcetitle": "Thromb Res"
                        },
                        "ce:source-text": "Chiasakul T, Evans CR, Spyropoulos AC, Raskob G, Crowther M, Cuker A. Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis. Thromb Res. 2019; 184:58-61."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tao DL, Bien JY, DeLoughery TG, Shatzel JJ. Extended thromboprophylaxis with direct oral anticoagulants for medical patients: A systematic review and meta-analysis. Blood. 2017; 129(5):653-655.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Extended thromboprophylaxis with direct oral anticoagulants for medical patients: A systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85014831738",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "129",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "653",
                                    "@last": "655"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "DL",
                                    "@_fa": "true",
                                    "ce:surname": "Tao",
                                    "ce:indexed-name": "Tao DL"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JY",
                                    "@_fa": "true",
                                    "ce:surname": "Bien",
                                    "ce:indexed-name": "Bien JY"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "TG",
                                    "@_fa": "true",
                                    "ce:surname": "DeLoughery",
                                    "ce:indexed-name": "DeLoughery TG"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "JJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Shatzel",
                                    "ce:indexed-name": "Shatzel JJ."
                                }
                            ]},
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Tao DL, Bien JY, DeLoughery TG, Shatzel JJ. Extended thromboprophylaxis with direct oral anticoagulants for medical patients: A systematic review and meta-analysis. Blood. 2017; 129(5):653-655."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: Prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018; 2(22):3198-3225.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "American Society of Hematology 2018 guidelines for management of venous thromboembolism: Prophylaxis for hospitalized and nonhospitalized medical patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85057250267",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2",
                                    "@issue": "22"
                                },
                                "pagerange": {
                                    "@first": "3198",
                                    "@last": "3225"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HJ",
                                        "@_fa": "true",
                                        "ce:surname": "Schünemann",
                                        "ce:indexed-name": "Schunemann HJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Cushman",
                                        "ce:indexed-name": "Cushman M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AE",
                                        "@_fa": "true",
                                        "ce:surname": "Burnett",
                                        "ce:indexed-name": "Burnett AE"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: Prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018; 2(22):3198-3225."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-associated thrombosis: An overview of mechanisms, risk factors, and treatment. Cancers (Basel). 2018; 10(10):380.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cancer-associated thrombosis: An overview of mechanisms, risk factors, and treatment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85055516302",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "10"
                                },
                                "pagerange": {"@first": "380"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "NB",
                                    "@_fa": "true",
                                    "ce:surname": "Abdol Razak",
                                    "ce:indexed-name": "Abdol Razak NB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Jones",
                                    "ce:indexed-name": "Jones G"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Bhandari",
                                    "ce:indexed-name": "Bhandari M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "MC",
                                    "@_fa": "true",
                                    "ce:surname": "Berndt",
                                    "ce:indexed-name": "Berndt MC"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Metharom",
                                    "ce:indexed-name": "Metharom P."
                                }
                            ]},
                            "ref-sourcetitle": "Cancers (Basel)"
                        },
                        "ce:source-text": "Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-associated thrombosis: An overview of mechanisms, risk factors, and treatment. Cancers (Basel). 2018; 10(10):380."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Akl EA, Terrenato I, Barba M, et al. Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: A systematic review and meta-analysis. Arch Intern Med. 2008; 168(12):1261-1269.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: A systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "46449106401",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "168",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1261",
                                    "@last": "1269"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "EA",
                                        "@_fa": "true",
                                        "ce:surname": "Akl",
                                        "ce:indexed-name": "Akl EA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Terrenato",
                                        "ce:indexed-name": "Terrenato I"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Barba",
                                        "ce:indexed-name": "Barba M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Arch Intern Med"
                        },
                        "ce:source-text": "Akl EA, Terrenato I, Barba M, et al. Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: A systematic review and meta-analysis. Arch Intern Med. 2008; 168(12):1261-1269."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Di Nisio M, Porreca E, Candeloro M, De Tursi M, Russi I, Rutjes AW. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database Syst Rev. 2016; 12(12):CD008500.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84907168847",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "12"
                                },
                                "pagerange": {"@first": "CD008500"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Di Nisio",
                                    "ce:indexed-name": "Di Nisio M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E",
                                    "@_fa": "true",
                                    "ce:surname": "Porreca",
                                    "ce:indexed-name": "Porreca E"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Candeloro",
                                    "ce:indexed-name": "Candeloro M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "De Tursi",
                                    "ce:indexed-name": "De Tursi M"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Russi",
                                    "ce:indexed-name": "Russi I"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "AW.",
                                    "@_fa": "true",
                                    "ce:surname": "Rutjes",
                                    "ce:indexed-name": "Rutjes AW."
                                }
                            ]},
                            "ref-sourcetitle": "Cochrane Database Syst Rev"
                        },
                        "ce:source-text": "Di Nisio M, Porreca E, Candeloro M, De Tursi M, Russi I, Rutjes AW. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database Syst Rev. 2016; 12(12):CD008500."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006; 119(1):60-68.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Incidence of venous thromboembolism in patients hospitalized with cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "30944433554",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "119",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "60",
                                    "@last": "68"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "PD",
                                    "@_fa": "true",
                                    "ce:surname": "Stein",
                                    "ce:indexed-name": "Stein PD"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Beemath",
                                    "ce:indexed-name": "Beemath A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "FA",
                                    "@_fa": "true",
                                    "ce:surname": "Meyers",
                                    "ce:indexed-name": "Meyers FA"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E",
                                    "@_fa": "true",
                                    "ce:surname": "Skaf",
                                    "ce:indexed-name": "Skaf E"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Sanchez",
                                    "ce:indexed-name": "Sanchez J"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "RE.",
                                    "@_fa": "true",
                                    "ce:surname": "Olson",
                                    "ce:indexed-name": "Olson RE."
                                }
                            ]},
                            "ref-sourcetitle": "Am J Med"
                        },
                        "ce:source-text": "Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006; 119(1):60-68."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Prandoni P, Lensing AWA, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002; 100(10):3484-3488.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037111563",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "100",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "3484",
                                    "@last": "3488"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Prandoni",
                                        "ce:indexed-name": "Prandoni P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "AWA",
                                        "@_fa": "true",
                                        "ce:surname": "Lensing",
                                        "ce:indexed-name": "Lensing AWA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Piccioli",
                                        "ce:indexed-name": "Piccioli A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Prandoni P, Lensing AWA, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002; 100(10):3484-3488."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kaatz S, Ahmad D, Spyropoulos AC, Schulman S; Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: Communication from the SSC of the ISTH. J Thromb Haemost. 2015; 13(11):2119-2126.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: Communication from the SSC of the ISTH"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84946543850",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "2119",
                                    "@last": "2126"
                                }
                            },
                            "ref-text": "Subcommittee on Control of Anticoagulation",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Kaatz",
                                    "ce:indexed-name": "Kaatz S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Ahmad",
                                    "ce:indexed-name": "Ahmad D"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AC",
                                    "@_fa": "true",
                                    "ce:surname": "Spyropoulos",
                                    "ce:indexed-name": "Spyropoulos AC"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Schulman",
                                    "ce:indexed-name": "Schulman S"
                                }
                            ]},
                            "ref-sourcetitle": "J Thromb Haemost"
                        },
                        "ce:source-text": "Kaatz S, Ahmad D, Spyropoulos AC, Schulman S; Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: Communication from the SSC of the ISTH. J Thromb Haemost. 2015; 13(11):2119-2126."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Goldhaber SZ, Leizorovicz A, Kakkar AK, et al; ADOPT trial investigators. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med. 2011; 365(23):2167-2177.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "83155193223",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "365",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "2167",
                                    "@last": "2177"
                                }
                            },
                            "ref-text": "ADOPT trial investigators",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SZ",
                                        "@_fa": "true",
                                        "ce:surname": "Goldhaber",
                                        "ce:indexed-name": "Goldhaber SZ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Leizorovicz",
                                        "ce:indexed-name": "Leizorovicz A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AK",
                                        "@_fa": "true",
                                        "ce:surname": "Kakkar",
                                        "ce:indexed-name": "Kakkar AK"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Goldhaber SZ, Leizorovicz A, Kakkar AK, et al; ADOPT trial investigators. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med. 2011; 365(23):2167-2177."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Spyropoulos AC, Ageno W, Albers GW, et al; MARINER investigators. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness. N Engl J Med. 2018; 379(12):1118-1127.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Rivaroxaban for thromboprophylaxis after hospitalization for medical illness"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85053024125",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "379",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1118",
                                    "@last": "1127"
                                }
                            },
                            "ref-text": "MARINER investigators",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AC",
                                        "@_fa": "true",
                                        "ce:surname": "Spyropoulos",
                                        "ce:indexed-name": "Spyropoulos AC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Ageno",
                                        "ce:indexed-name": "Ageno W"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GW",
                                        "@_fa": "true",
                                        "ce:surname": "Albers",
                                        "ce:indexed-name": "Albers GW"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Spyropoulos AC, Ageno W, Albers GW, et al; MARINER investigators. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness. N Engl J Med. 2018; 379(12):1118-1127."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cohen AT, Spiro TE, Büller HR, et al; MAGELLAN investigators. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med. 2013; 368(6):513-523.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Rivaroxaban for thromboprophylaxis in acutely ill medical patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84873514413",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "368",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "513",
                                    "@last": "523"
                                }
                            },
                            "ref-text": "MAGELLAN investigators",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AT",
                                        "@_fa": "true",
                                        "ce:surname": "Cohen",
                                        "ce:indexed-name": "Cohen AT"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "TE",
                                        "@_fa": "true",
                                        "ce:surname": "Spiro",
                                        "ce:indexed-name": "Spiro TE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "HR",
                                        "@_fa": "true",
                                        "ce:surname": "Büller",
                                        "ce:indexed-name": "Buller HR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Cohen AT, Spiro TE, Büller HR, et al; MAGELLAN investigators. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med. 2013; 368(6):513-523."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hull RD, Schellong SM, Tapson VF, et al; EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: A randomized trial. Ann Intern Med. 2010; 153(1):8-18.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: A randomized trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77955951754",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "153",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "8",
                                    "@last": "18"
                                }
                            },
                            "ref-text": "EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RD",
                                        "@_fa": "true",
                                        "ce:surname": "Hull",
                                        "ce:indexed-name": "Hull RD"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Schellong",
                                        "ce:indexed-name": "Schellong SM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "VF",
                                        "@_fa": "true",
                                        "ce:surname": "Tapson",
                                        "ce:indexed-name": "Tapson VF"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Intern Med"
                        },
                        "ce:source-text": "Hull RD, Schellong SM, Tapson VF, et al; EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: A randomized trial. Ann Intern Med. 2010; 153(1):8-18."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cohen AT, Harrington RA, Goldhaber SZ, et al; APEX investigators. Extended thromboprophylaxis with betrixaban in acutely ill medical patients. N Engl J Med. 2016; 375(6):534-544.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Extended thromboprophylaxis with betrixaban in acutely ill medical patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84981709094",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "375",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "534",
                                    "@last": "544"
                                }
                            },
                            "ref-text": "APEX investigators",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AT",
                                        "@_fa": "true",
                                        "ce:surname": "Cohen",
                                        "ce:indexed-name": "Cohen AT"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrington",
                                        "ce:indexed-name": "Harrington RA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SZ",
                                        "@_fa": "true",
                                        "ce:surname": "Goldhaber",
                                        "ce:indexed-name": "Goldhaber SZ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Cohen AT, Harrington RA, Goldhaber SZ, et al; APEX investigators. Extended thromboprophylaxis with betrixaban in acutely ill medical patients. N Engl J Med. 2016; 375(6):534-544."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ageno W, Lopes RD, Yee MK, et al. Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: Insights from the APEX trial. J Thromb Thrombolysis. 2020; 49(2):214-219.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: Insights from the APEX trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85071747587",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "49",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "214",
                                    "@last": "219"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Ageno",
                                        "ce:indexed-name": "Ageno W"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RD",
                                        "@_fa": "true",
                                        "ce:surname": "Lopes",
                                        "ce:indexed-name": "Lopes RD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MK",
                                        "@_fa": "true",
                                        "ce:surname": "Yee",
                                        "ce:indexed-name": "Yee MK"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thromb Thrombolysis"
                        },
                        "ce:source-text": "Ageno W, Lopes RD, Yee MK, et al. Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: Insights from the APEX trial. J Thromb Thrombolysis. 2020; 49(2):214-219."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Khorana AA, Soff GA, Kakkar AK, et al; CASSINI investigators. Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer. N Engl J Med. 2019; 380(8):720-728.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061961689",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "380",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "720",
                                    "@last": "728"
                                }
                            },
                            "ref-text": "CASSINI investigators",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AA",
                                        "@_fa": "true",
                                        "ce:surname": "Khorana",
                                        "ce:indexed-name": "Khorana AA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "GA",
                                        "@_fa": "true",
                                        "ce:surname": "Soff",
                                        "ce:indexed-name": "Soff GA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AK",
                                        "@_fa": "true",
                                        "ce:surname": "Kakkar",
                                        "ce:indexed-name": "Kakkar AK"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Khorana AA, Soff GA, Kakkar AK, et al; CASSINI investigators. Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer. N Engl J Med. 2019; 380(8):720-728."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Carrier M, Abou-Nassar K, Mallick R, et al; AVERT investigators. Apixaban to prevent venous thromboembolism in patients with cancer. N Engl J Med. 2019; 380(8):711-719.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Apixaban to prevent venous thromboembolism in patients with cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85058848099",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "380",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "711",
                                    "@last": "719"
                                }
                            },
                            "ref-text": "AVERT investigators",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Carrier",
                                        "ce:indexed-name": "Carrier M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Abou-Nassar",
                                        "ce:indexed-name": "Abou-Nassar K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Mallick",
                                        "ce:indexed-name": "Mallick R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Carrier M, Abou-Nassar K, Mallick R, et al; AVERT investigators. Apixaban to prevent venous thromboembolism in patients with cancer. N Engl J Med. 2019; 380(8):711-719."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Felder S, Rasmussen MS, King R, et al. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2018; 11(11):CD004318.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85057488144",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "11"
                                },
                                "pagerange": {"@first": "CD004318"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Felder",
                                        "ce:indexed-name": "Felder S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MS",
                                        "@_fa": "true",
                                        "ce:surname": "Rasmussen",
                                        "ce:indexed-name": "Rasmussen MS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "King",
                                        "ce:indexed-name": "King R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cochrane Database Syst Rev"
                        },
                        "ce:source-text": "Felder S, Rasmussen MS, King R, et al. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2018; 11(11):CD004318."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Fanikos J, Rao A, Seger AC, et al. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge. Am J Med. 2011; 124(12):1143-1150.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge"},
                            "refd-itemidlist": {"itemid": {
                                "$": "81855216397",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "124",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1143",
                                    "@last": "1150"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Fanikos",
                                        "ce:indexed-name": "Fanikos J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Rao",
                                        "ce:indexed-name": "Rao A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AC",
                                        "@_fa": "true",
                                        "ce:surname": "Seger",
                                        "ce:indexed-name": "Seger AC"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Med"
                        },
                        "ce:source-text": "Fanikos J, Rao A, Seger AC, et al. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge. Am J Med. 2011; 124(12):1143-1150."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Di Nisio M, Candeloro M, Rutjes AWS, Galli V, Tritto M, Porreca E. Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness. Thromb Res. 2018; 169:44-49.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85049758254",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "169"},
                                "pagerange": {
                                    "@first": "44",
                                    "@last": "49"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Di Nisio",
                                    "ce:indexed-name": "Di Nisio M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Candeloro",
                                    "ce:indexed-name": "Candeloro M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AWS",
                                    "@_fa": "true",
                                    "ce:surname": "Rutjes",
                                    "ce:indexed-name": "Rutjes AWS"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "V",
                                    "@_fa": "true",
                                    "ce:surname": "Galli",
                                    "ce:indexed-name": "Galli V"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Tritto",
                                    "ce:indexed-name": "Tritto M"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Porreca",
                                    "ce:indexed-name": "Porreca E."
                                }
                            ]},
                            "ref-sourcetitle": "Thromb Res"
                        },
                        "ce:source-text": "Di Nisio M, Candeloro M, Rutjes AWS, Galli V, Tritto M, Porreca E. Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness. Thromb Res. 2018; 169:44-49."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Patell R, Gutierrez A, Rybicki L, Khorana AA. Identifying predictors for bleeding in hospitalized cancer patients: A cohort study. Thromb Res. 2017; 158: 38-43.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Identifying predictors for bleeding in hospitalized cancer patients: A cohort study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85027415853",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "158"},
                                "pagerange": {
                                    "@first": "38",
                                    "@last": "43"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Patell",
                                    "ce:indexed-name": "Patell R"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Gutierrez",
                                    "ce:indexed-name": "Gutierrez A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Rybicki",
                                    "ce:indexed-name": "Rybicki L"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "AA.",
                                    "@_fa": "true",
                                    "ce:surname": "Khorana",
                                    "ce:indexed-name": "Khorana AA."
                                }
                            ]},
                            "ref-sourcetitle": "Thromb Res"
                        },
                        "ce:source-text": "Patell R, Gutierrez A, Rybicki L, Khorana AA. Identifying predictors for bleeding in hospitalized cancer patients: A cohort study. Thromb Res. 2017; 158: 38-43."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Neumann I, Izcovich A, Zhang Y, et al. DOACs vs LMWHs in hospitalized medical patients: A systematic review and meta-analysis that informed 2018 ASH guidelines. Blood Adv. 2020; 4(7):1512-1517.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "DOACs vs LMWHs in hospitalized medical patients: A systematic review and meta-analysis that informed 2018 ASH guidelines"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85083699247",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "1512",
                                    "@last": "1517"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Neumann",
                                        "ce:indexed-name": "Neumann I"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Izcovich",
                                        "ce:indexed-name": "Izcovich A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang Y"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Neumann I, Izcovich A, Zhang Y, et al. DOACs vs LMWHs in hospitalized medical patients: A systematic review and meta-analysis that informed 2018 ASH guidelines. Blood Adv. 2020; 4(7):1512-1517."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Carrier M, Khorana AA, Moretto P, Le Gal G, Karp R, Zwicker JI. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer. Am J Med. 2014; 127(1):82-86.e1.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84891599590",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "127",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "82",
                                    "@last": "86"
                                }
                            },
                            "ref-text": "e1",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Carrier",
                                    "ce:indexed-name": "Carrier M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "AA",
                                    "@_fa": "true",
                                    "ce:surname": "Khorana",
                                    "ce:indexed-name": "Khorana AA"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Moretto",
                                    "ce:indexed-name": "Moretto P"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Le Gal",
                                    "ce:indexed-name": "Le Gal G"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Karp",
                                    "ce:indexed-name": "Karp R"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "JI.",
                                    "@_fa": "true",
                                    "ce:surname": "Zwicker",
                                    "ce:indexed-name": "Zwicker JI."
                                }
                            ]},
                            "ref-sourcetitle": "Am J Med"
                        },
                        "ce:source-text": "Carrier M, Khorana AA, Moretto P, Le Gal G, Karp R, Zwicker JI. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer. Am J Med. 2014; 127(1):82-86.e1."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zwicker JI, Roopkumar J, Puligandla M, et al. Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: A randomized, double-blinded multicenter phase 2 trial. Blood Adv. 2020; 4(10):2254-2260.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: A randomized, double-blinded multicenter phase 2 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85089830662",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "2254",
                                    "@last": "2260"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JI",
                                        "@_fa": "true",
                                        "ce:surname": "Zwicker",
                                        "ce:indexed-name": "Zwicker JI"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Roopkumar",
                                        "ce:indexed-name": "Roopkumar J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Puligandla",
                                        "ce:indexed-name": "Puligandla M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Zwicker JI, Roopkumar J, Puligandla M, et al. Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: A randomized, double-blinded multicenter phase 2 trial. Blood Adv. 2020; 4(10):2254-2260."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Madenci AL, Weil BR, Liu Q, et al. Long-term risk of venous thromboembolism in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2018; 36(31):3144-3151.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Long-term risk of venous thromboembolism in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85055810071",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "31"
                                },
                                "pagerange": {
                                    "@first": "3144",
                                    "@last": "3151"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AL",
                                        "@_fa": "true",
                                        "ce:surname": "Madenci",
                                        "ce:indexed-name": "Madenci AL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BR",
                                        "@_fa": "true",
                                        "ce:surname": "Weil",
                                        "ce:indexed-name": "Weil BR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu Q"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Madenci AL, Weil BR, Liu Q, et al. Long-term risk of venous thromboembolism in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2018; 36(31):3144-3151."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Strongman H, Gadd S, Matthews A, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: A population-based cohort study using multiple linked UK electronic health records databases. Lancet. 2019; 394(10203):1041-1054.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: A population-based cohort study using multiple linked UK electronic health records databases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85072254226",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "394",
                                    "@issue": "10203"
                                },
                                "pagerange": {
                                    "@first": "1041",
                                    "@last": "1054"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Strongman",
                                        "ce:indexed-name": "Strongman H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Gadd",
                                        "ce:indexed-name": "Gadd S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Matthews",
                                        "ce:indexed-name": "Matthews A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Strongman H, Gadd S, Matthews A, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: A population-based cohort study using multiple linked UK electronic health records databases. Lancet. 2019; 394(10203):1041-1054."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Patell R, Rybicki L, McCrae KR, Khorana AA. Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool. Am J Hematol. 2017; 92(6):501-507.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85019005371",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "92",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "501",
                                    "@last": "507"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Patell",
                                    "ce:indexed-name": "Patell R"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Rybicki",
                                    "ce:indexed-name": "Rybicki L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "KR",
                                    "@_fa": "true",
                                    "ce:surname": "McCrae",
                                    "ce:indexed-name": "McCrae KR"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "AA.",
                                    "@_fa": "true",
                                    "ce:surname": "Khorana",
                                    "ce:indexed-name": "Khorana AA."
                                }
                            ]},
                            "ref-sourcetitle": "Am J Hematol"
                        },
                        "ce:source-text": "Patell R, Rybicki L, McCrae KR, Khorana AA. Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool. Am J Hematol. 2017; 92(6):501-507."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest. 2010; 138(5):1093-1100.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77955872745",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "138",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1093",
                                    "@last": "1100"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Pisters",
                                    "ce:indexed-name": "Pisters R"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "DA",
                                    "@_fa": "true",
                                    "ce:surname": "Lane",
                                    "ce:indexed-name": "Lane DA"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Nieuwlaat",
                                    "ce:indexed-name": "Nieuwlaat R"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "CB",
                                    "@_fa": "true",
                                    "ce:surname": "de Vos",
                                    "ce:indexed-name": "de Vos CB"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "HJGM",
                                    "@_fa": "true",
                                    "ce:surname": "Crijns",
                                    "ce:indexed-name": "Crijns HJGM"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "GYH.",
                                    "@_fa": "true",
                                    "ce:surname": "Lip",
                                    "ce:indexed-name": "Lip GYH."
                                }
                            ]},
                            "ref-sourcetitle": "Chest"
                        },
                        "ce:source-text": "Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest. 2010; 138(5):1093-1100."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Rossel A, Robert-Ebadi H, Combescure C, et al. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis. PLoS One. 2019; 14(3):e0213940.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85063341506",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "e0213940"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Rossel",
                                        "ce:indexed-name": "Rossel A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Robert-Ebadi",
                                        "ce:indexed-name": "Robert-Ebadi H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Combescure",
                                        "ce:indexed-name": "Combescure C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Rossel A, Robert-Ebadi H, Combescure C, et al. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis. PLoS One. 2019; 14(3):e0213940."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Lee JH, Lee JH, Jo K-W, Huh J-W, Oh Y-M, Lee JS. Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers. J Gynecol Oncol. 2020; 31(1):e10.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85076448465",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "31",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "e10"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JH",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee JH"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JH",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee JH"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K-W",
                                    "@_fa": "true",
                                    "ce:surname": "Jo",
                                    "ce:indexed-name": "Jo K-W"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J-W",
                                    "@_fa": "true",
                                    "ce:surname": "Huh",
                                    "ce:indexed-name": "Huh J-W"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "Y-M",
                                    "@_fa": "true",
                                    "ce:surname": "Oh",
                                    "ce:indexed-name": "Oh Y-M"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "JS.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee JS."
                                }
                            ]},
                            "ref-sourcetitle": "J Gynecol Oncol"
                        },
                        "ce:source-text": "Lee JH, Lee JH, Jo K-W, Huh J-W, Oh Y-M, Lee JS. Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers. J Gynecol Oncol. 2020; 31(1):e10."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "McBane RD II, Wysokinski WE, Le-Rademacher JG, et al. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial. J Thromb Haemost. 2020; 18(2):411-421.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85075059646",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "411",
                                    "@last": "421"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RD",
                                        "@_fa": "true",
                                        "ce:surname": "McBane",
                                        "ce:indexed-name": "McBane RD"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WE",
                                        "@_fa": "true",
                                        "ce:surname": "Wysokinski",
                                        "ce:indexed-name": "Wysokinski WE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JG",
                                        "@_fa": "true",
                                        "ce:surname": "Le-Rademacher",
                                        "ce:indexed-name": "Le-Rademacher JG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thromb Haemost"
                        },
                        "ce:source-text": "McBane RD II, Wysokinski WE, Le-Rademacher JG, et al. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial. J Thromb Haemost. 2020; 18(2):411-421."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Agnelli G, Becattini C, Meyer G, et al; Caravaggio investigators. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020; 382(17):1599-1607.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Apixaban for the treatment of venous thromboembolism associated with cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85083464204",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "382",
                                    "@issue": "17"
                                },
                                "pagerange": {
                                    "@first": "1599",
                                    "@last": "1607"
                                }
                            },
                            "ref-text": "Caravaggio investigators",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Agnelli",
                                        "ce:indexed-name": "Agnelli G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Becattini",
                                        "ce:indexed-name": "Becattini C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Meyer",
                                        "ce:indexed-name": "Meyer G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Agnelli G, Becattini C, Meyer G, et al; Caravaggio investigators. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020; 382(17):1599-1607."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Boston",
            "@id": "60002746",
            "affilname": "Harvard Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Cleveland",
            "@id": "60032732",
            "affilname": "Taussig Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032732",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85105062344",
        "dc:description": "Hospitalized medically ill patients with cancer are at increased risk of both venous thromboembolism and bleeding. The safety and efficacy of extended thromboprophylaxis in patients with cancer are unclear.Weconducted a systematic review and meta-analysis of the literature using ofMEDLINE, EMBASE, and the Cochrane CENTRAL databases to identify cancer subgroups enrolled in randomized controlled trials evaluating extended thromboprophylaxis following hospitalization. The primary outcomes were symptomatic and incidental venous thromboembolic events and hemorrhage (major hemorrhage and clinically relevant nonmajor bleeding). Four randomized controlled trials reported the outcomes of extended thromboprophylaxis in 3655medically ill patients with active or history of cancer. The rates of venous thromboembolic events were similar between the extended-duration and standardduration groups (odds ratio [OR], 0.85; 95% confidence interval [CI], 0.61-1.18; I2=0%). However, major and clinically relevant nonmajor bleeding occurred significantly more frequently in the extended-duration thromboprophylaxis group (OR, 2.10; 95% CI, 1.33-3.35; I2 = 8%). Extended thromboprophylaxis in hospitalized medically ill patientswith cancerwas not associatedwith a reduced rate of venous thromboembolic events but was associated with increased risk of hemorrhage.",
        "pubmed-id": "33861298",
        "prism:coverDate": "2021-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85105062344",
        "dc:creator": {"author": [{
            "ce:given-name": "Soravis",
            "preferred-name": {
                "ce:given-name": "Soravis",
                "ce:initials": "S.",
                "ce:surname": "Osataphan",
                "ce:indexed-name": "Osataphan S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002746",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746"
            },
            "ce:surname": "Osataphan",
            "@auid": "57189993888",
            "author-url": "https://api.elsevier.com/content/author/author_id/57189993888",
            "ce:indexed-name": "Osataphan S."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85105062344"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105062344&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85105062344&origin=inward"
            }
        ],
        "source-id": "21100886825",
        "citedby-count": "7",
        "prism:volume": "5",
        "subtype": "re",
        "dc:title": "Extended thromboprophylaxis for medically ill patients with cancer: A systemic review and meta-analysis",
        "openaccess": "1",
        "prism:issn": "24739537 24739529",
        "publishercopyright": "© 2021 by The American Society of Hematology.",
        "prism:issueIdentifier": "8",
        "subtypeDescription": "Review",
        "prism:publicationName": "Blood Advances",
        "prism:pageRange": "2055-2062",
        "prism:endingPage": "2062",
        "openaccessFlag": "true",
        "prism:doi": "10.1182/BLOODADVANCES.2020004118",
        "prism:startingPage": "2055",
        "dc:identifier": "SCOPUS_ID:85105062344",
        "dc:publisher": "American Society of Hematology"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Hematology",
        "@code": "2720",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Soravis",
            "preferred-name": {
                "ce:given-name": "Soravis",
                "ce:initials": "S.",
                "ce:surname": "Osataphan",
                "ce:indexed-name": "Osataphan S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002746",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746"
            },
            "ce:surname": "Osataphan",
            "@auid": "57189993888",
            "author-url": "https://api.elsevier.com/content/author/author_id/57189993888",
            "ce:indexed-name": "Osataphan S."
        },
        {
            "ce:given-name": "Rushad",
            "preferred-name": {
                "ce:given-name": "Rushad",
                "ce:initials": "R.",
                "ce:surname": "Patell",
                "ce:indexed-name": "Patell R."
            },
            "@seq": "2",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002746",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746"
            },
            "ce:surname": "Patell",
            "@auid": "54682133800",
            "author-url": "https://api.elsevier.com/content/author/author_id/54682133800",
            "ce:indexed-name": "Patell R."
        },
        {
            "ce:given-name": "Thita",
            "preferred-name": {
                "ce:given-name": "Thita",
                "ce:initials": "T.",
                "ce:surname": "Chiasakul",
                "ce:indexed-name": "Chiasakul T."
            },
            "@seq": "3",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002746",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Chiasakul",
            "@auid": "56938997200",
            "author-url": "https://api.elsevier.com/content/author/author_id/56938997200",
            "ce:indexed-name": "Chiasakul T."
        },
        {
            "ce:given-name": "Alok A.",
            "preferred-name": {
                "ce:given-name": "Alok A.",
                "ce:initials": "A.A.",
                "ce:surname": "Khorana",
                "ce:indexed-name": "Khorana A.A."
            },
            "@seq": "4",
            "ce:initials": "A.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60032732",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032732"
            },
            "ce:surname": "Khorana",
            "@auid": "7003928027",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003928027",
            "ce:indexed-name": "Khorana A.A."
        },
        {
            "ce:given-name": "Jeffrey I.",
            "preferred-name": {
                "ce:given-name": "Jeffrey I.",
                "ce:initials": "J.I.",
                "ce:surname": "Zwicker",
                "ce:indexed-name": "Zwicker J.I."
            },
            "@seq": "5",
            "ce:initials": "J.I.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002746",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746"
            },
            "ce:surname": "Zwicker",
            "@auid": "7003326377",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003326377",
            "ce:indexed-name": "Zwicker J.I."
        }
    ]}
}}